StockNews.AI
TWST
StockNews.AI
15 days

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

1. Twist Bioscience reported strong financial results for Q3 fiscal 2025. 2. CEO emphasized disciplined cost-management and a strong balance sheet.

2m saved
Insight
Article

FAQ

Why Bullish?

Strong financial results suggest healthy growth, analogous to similar firms experiencing upward trends post-earnings.

How important is it?

Positive earnings reports typically drive stock prices; investors respond favorably to profitability indicators.

Why Short Term?

Immediate investor sentiment likely boosts TWST's stock, as seen in previous quarterly reports.

Related Companies

CRSPRSGEN
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025. “A strong balance sheet and disciplined cost-management underpin our focused business execution,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. Visit the Events and Presentations page of the Investor Relations section under the “Company” ta.

Related News